Prenatal diagnosis and perinatal management of maternal-fetal congenital parvovirus B19 infection

Taiwanese Journal of Obstetrics and Gynecology

Volumn 46, Issue 4, 2007, Pages 417-422

  Hsu, Shih Tien ^a   Chen, Yi Ting ^a   Huang, Ying Fen ^a   Yeh, Tzu Ting ^a   Chen, Wei Chih ^a   Ho, Esther Shih Chu ^a   Chou, Min Min ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hydrops fetalis; Intraperitoneal transfusion; Parvovirus B19

Indexed keywords

DIGOXIN; HEMOGLOBIN F;

ADULT; AMNION FLUID; AMNION FLUID ANALYSIS; APGAR SCORE; ARTICLE; ASCITES; CASE REPORT; CLINICAL FEATURE; CORDOCENTESIS; DIGITALIZATION; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS; FETUS CIRCULATION; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IRON THERAPY; LABORATORY TEST; MALE; MATERNAL WELFARE; NEWBORN; NEWBORN INTENSIVE CARE; PARVOVIRUS INFECTION; PERINATAL CARE; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS;

EID: 38049035767     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)60014-5     Document Type: Article

References (16)

1. Guerrero LD. Fetal parvovirus infection. Available at: http://www.thefetus.net/page.php?id=155 [Date accessed: 21 December 2006]
2. Cunningham D, Rennels MB. Parvovirus B19 infection. Available at: http://www.emedicine.com/ped/topic192.htm [Date accessed: 21 December 2006]
3. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357:1494-7.
4. Gillespie SM, Cartter ML, Asch S, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 1990;263:2061-5.
5. von Kaisenberg CS, Bender G, Scheewe J, et al. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 2001; 16:427-3.
6. Nagel HT, de Haan TR, Vandenbussche FP, Oepkes D, Walther FJ. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007;109:42-7.
7. Delle Chiaie L, Buck G, Grab D, Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 2001;18: 232-6.
8. st edition. Oxford: Blackwell Scientific Publications, 1989:118-53.
9. Bowman JM, Manning FA. Intrauterine fetal transfusions: Winnipeg 1982. Obstet Gynecol 1983;61:203-9.
10. Bowman JM. Maternal blood group immunization. In: Eden RD, Boehm FH, eds. Assessment and Care of the Fetus, international edition. East Norwalk: Appleton & Lange, 1990: 749-66.
11. Watts DH, Luthy DA, Benedetti TJ, Cyr DR, Easterling TR, Hickok D. Intraperitoneal fetal transfusion under direct ultrasound guidance. Obstet Gynecol 1988;71:84-8.
12. Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 1984;150:769-74.
13. Smoleniec JS, Pillai M. Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynaecol 1994; 101:1079-81.
14. Forestier F, Tissot JD, Vial Y, Daffos F, Hohlfeld P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 1999;104: 925-7.
15. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989;9: 105-14.
16. Frishman WH, O'Brien M, Naseer N, Anandasabapathy S. Innovative drug treatments for viral and autoimmune myocarditis. Heart Dis 2002;4:171-83.